FAVIPIRAVIR

FAVIPIRAVIR: Favipiravir is an antiviral drug used to treat certain viral infections. It is primarily used for the treatment of influenza, including seasonal influenza and avian influenza (bird flu), as well as other viral infections like Ebola and COVID-19.

The exact mechanism of action of favipiravir is not fully understood, but it is believed to work by inhibiting the RNA-dependent RNA polymerase enzyme, which is required for viral replication. This inhibition prevents the virus from multiplying and spreading within the body.

The recommended dose of favipiravir varies depending on the indication and the patient’s weight. For the treatment of influenza, the typical dose is 1600 mg (for patients weighing 40-80 kg) or 1800 mg (for patients weighing more than 80 kg) taken as an initial loading dose, followed by 600 mg twice daily for 4-5 days. For the treatment of COVID-19, the dosing regimen may vary, and it is best to follow the specific recommendations provided by healthcare professionals.

As with any medication, favipiravir may cause side effects. Some common side effects include diarrhea, nausea, vomiting, abdominal pain, headache, and elevated uric acid levels in the blood (which may lead to gout). Less frequently, it may cause liver function abnormalities, skin reactions, and changes in blood cell counts. It is important to discuss any concerns or potential side effects with a healthcare professional before starting this medication.